|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
GDC-0349
Description of
GDC-0349:
GDC-0349 is a small molecule
anticaner drug candidate, being developed by Genentech. As of July
2012, Genentech has filed phase I trial of GDC-0349 for evaluating
the Safety and Tolerability of GDC-0349 in Patients With Locally
Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma
Current developer: Genentech.
|
MedKoo Code#:
205839
|
|
Name: GDC-0349
|
|
CAS#:
1207360-89-1
Synonym:
GDC-0349; GDC 0349; GDC0349; RG7603.
IUPAC/Chemical name:
(S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea
|
|
Chemical structure
|
Theoretical analysis
|
|
|
MedKoo Code#: 205839
Name: GDC-0349
CAS#: 1207360-89-1
Chemical Formula: C24H32N6O3
Exact Mass: 452.25359
Molecular Weight: 452.55
Elemental Analysis: C, 63.70; H, 7.13; N, 18.57; O, 10.61
|
|
Availability and price:
GDC-0349 (98%) is
is available soon.
100 mg / $1,650.00
200 mg / $2,250.00
500 mg / $3,250.00
1.0gram / $4,250.00
(#$%SM*&()CHEM)
To inquire quotation and lead time or to ask questions, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Highlights of recent research using this agent
|
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
